Name | Number of supported studies | Average coverage | |
---|---|---|---|
renal alpha-intercalated cell | 7 studies | 58% ± 17% | |
glutamatergic neuron | 4 studies | 26% ± 4% | |
hepatocyte | 3 studies | 54% ± 14% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 48% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
kidney | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4106.08 | 226 / 226 | 99% | 27.67 | 400 / 406 |
kidney | 100% | 2958.43 | 89 / 89 | 91% | 15.94 | 818 / 901 |
pancreas | 100% | 1142.10 | 328 / 328 | 75% | 4.85 | 133 / 178 |
thymus | 100% | 667.05 | 650 / 653 | 62% | 2.84 | 375 / 605 |
lung | 74% | 174.14 | 429 / 578 | 66% | 6.56 | 761 / 1155 |
ovary | 97% | 710.88 | 174 / 180 | 39% | 2.25 | 168 / 430 |
adrenal gland | 100% | 2274.17 | 258 / 258 | 25% | 4.81 | 58 / 230 |
breast | 69% | 195.84 | 316 / 459 | 50% | 16.27 | 558 / 1118 |
intestine | 76% | 450.74 | 737 / 966 | 42% | 2.28 | 223 / 527 |
esophagus | 64% | 169.85 | 921 / 1445 | 49% | 4.21 | 89 / 183 |
heart | 94% | 567.53 | 811 / 861 | 0% | 0 | 0 / 0 |
brain | 57% | 167.43 | 1505 / 2642 | 35% | 2.58 | 248 / 705 |
stomach | 38% | 96.62 | 136 / 359 | 49% | 2.97 | 140 / 286 |
adipose | 83% | 254.78 | 997 / 1204 | 0% | 0 | 0 / 0 |
muscle | 82% | 295.03 | 661 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 80% | 166.46 | 1073 / 1335 | 0% | 0 | 0 / 0 |
spleen | 75% | 211.96 | 181 / 241 | 0% | 0 | 0 / 0 |
skin | 54% | 197.46 | 969 / 1809 | 9% | 0.95 | 41 / 472 |
prostate | 47% | 91.24 | 115 / 245 | 14% | 0.53 | 72 / 502 |
bladder | 24% | 32.48 | 5 / 21 | 31% | 1.85 | 157 / 504 |
uterus | 8% | 12.15 | 13 / 170 | 43% | 4.46 | 199 / 459 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.73 | 8 / 45 |
peripheral blood | 1% | 1.40 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0046627 | Biological process | negative regulation of insulin receptor signaling pathway |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0010008 | Cellular component | endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0030971 | Molecular function | receptor tyrosine kinase binding |
Gene name | GRB14 |
Protein name | Uncharacterized protein GRB14 Growth factor receptor bound protein 14 Growth factor receptor-bound protein 14 (GRB14 adapter protein) |
Synonyms | |
Description | FUNCTION: Adapter protein which modulates coupling of cell surface receptor kinases with specific signaling pathways. Binds to, and suppresses signals from, the activated insulin receptor (INSR). Potent inhibitor of insulin-stimulated MAPK3 phosphorylation. Plays a critical role regulating PDPK1 membrane translocation in response to insulin stimulation and serves as an adapter protein to recruit PDPK1 to activated insulin receptor, thus promoting PKB/AKT1 phosphorylation and transduction of the insulin signal. . |
Accessions | ENST00000263915.8 [Q14449-1] ENST00000446413.6 Q53QM9 Q53QQ0 C9JD37 Q14449 C9JLT6 ENST00000696453.2 [Q14449-2] ENST00000424693.1 |